Health & Safety

July 9, 2012

Neurotrauma, Psychological Health office partners with VA to study PTSD treatments

by Carey Phillips
Fort Detrick, Md.

Post-traumatic stress disorder is a common anxiety disorder that can stem from any traumatic event experienced by an individual.

While there are medications currently approved by the U.S. Food and Drug Administration to treat it, they are not sufficiently effective in treating combat-related post-traumatic stress commonly seen in service members and veterans.

The U.S. Army Medical Materiel Development Activity’s Neurotrauma and Psychological Health Project Management Office signed an interagency agreement with the Veterans Affairs Cooperative Studies Program, or VACSP, to jointly conduct and support clinical studies of pharmacotherapeutics for the treatment of combat-related Post-traumatic stress disorder, knowns as PTSD, in service members and veterans.

“The interagency agreement between USAMMDA and VACSP structures how the agencies will collaborate,” said Maj. Gary Wynn, research psychiatrist with the Neurotrauma and Psychological Health Project Management Office. “While the DOD may be funding the research effort, the VA is an equal partner in the project.”

“The VA is the primary location for Veterans to receive care so we need to be looking at their populations as well as those still on active duty,” he explained.

USAMMDA and VACSP will be working together to identify and develop alternate indications for existing FDA-approved drugs used to treat other disorders.

“While these drugs are FDA-approved, they are not approved for the treatment of PTSD,” said Wynn. “In fact, many of the drugs currently being used have little, or no research supporting their off-label use in treating PTSD.”

Currently, there are two drugs that are FDA-approved for treating PTSD. However, studies have shown that these drugs are less than 50 percent effective when it comes to treating combat-related PTSD. Additionally, the side effects from these drugs can be harmful to service members and veterans.

Although these drugs have helped victims of PTSD, worldwide they have shown limited benefit for service members and veterans struggling with the aftermath of combat.

“These studies are vital to understand if and how [the drugs in the collaborative USAMMDA and VACSP study] should be used in service members and veterans,” said Wynn.

According to Wynn, the collaboration between USAMMDA and the VA will ensure the highest quality of research.




All of this week's top headlines to your email every Friday.


 
 

 

Headlines August 28, 2014

News: After F-15 jet crash in Virginia, rescue helicopters search for pilot - Helicopters are searching for an Air National Guard pilot after his F-15 jet crashed in the mountains of Virginia this morning, military officials said.   Business: U.S. Air Force 3DELRR contract expected soon - The U.S. Air Force could award the contract for its...
 
 

News Briefs August 28, 2014

Russian directing new offensive in Ukraine The Obama administration believes Russia is leading a new military counteroffensive in Ukraine. U.S. State Department spokeswoman Jen Psaki says Russia has sent additional columns of tanks and armored vehicles into its neighbor’s territory. She says the incursions suggest a ìRussian-directed counteroffensive is likely underway in the contested e...
 
 
LM-C5

Double Deuce

A U.S. Air Force crew ferried the 22nd C-5M Super Galaxy from the Lockheed Martin facilities in Marietta, Ga., Aug. 25. Aircraft 86-0011 was ferried by a crew led by Maj. Gen. Dwyer L. Dennis, Director, Global Reach Programs, O...
 

 
Northrop Grumman photograph

First ever RQ-4 Global Hawk hits 100th flight on NASA mission

Northrop Grumman photograph A historical look at the first Global Hawk (AV1) during its maiden flight over Edwards Air Force Base, Calif., on Feb. 28, 1998. AV1 has made history again with its 100th flight in support of NASA en...
 
 

Northrop Grumman’s CIRCM system completes U.S. Army flight testing

Northrop Grumman’s Common Infrared Countermeasures system recently completed another round of U.S. Army testing by demonstrating its capabilities on a UH-60M Black Hawk helicopter. The flight test was conducted at Redstone Arsenal in Huntsville, Ala., by the Redstone Test Center. The Northrop Grumman CIRCM system was subjected to rigorous conditions over a six-week period, after...
 
 
NASA photograph by David Olive

NASA completes successful battery of tests on composite cryotank

https://www.youtube.com/embed/qkGI6JeNY0E?enablejsapi=1&rel=0 NASA photograph by David Olive One of the largest composite cryotanks ever built recently completed a battery of tests at NASA’s Marshall Space Flight Cen...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>